scholarly article | Q13442814 |
P356 | DOI | 10.1042/CS0680463 |
P698 | PubMed publication ID | 2578915 |
P2093 | author name string | Halliwell B | |
Griffiths E | |||
Gutteridge JM | |||
Rowley DA | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 463-467 | |
P577 | publication date | 1985-04-01 | |
P1433 | published in | Clinical Science | Q372419 |
P1476 | title | Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis | |
P478 | volume | 68 |
Q71950284 | 2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts |
Q39698504 | A case of transfusion independence in a patient with myelodysplastic syndrome using deferasirox, sustained for two years after stopping therapy |
Q71791026 | A kinetic study of the coupled iron-ceruloplasmin catalyzed oxidation of ascorbate in the presence of albumin |
Q47271385 | Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: implications for the pathogenesis of iron-overload disease |
Q47326291 | Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy. |
Q58197779 | Alcohol Mediates Increases in Hepatic and Serum Nonheme Iron Stores in a Rat Model for Alcohol-Induced Liver Injury |
Q39704703 | An iron-messenger system--a hypothesis |
Q36422475 | An overview of molecular aspects of iron metabolism |
Q36179770 | Anti-oxidant therapy: does it have a role in the treatment of human disease? |
Q38648362 | Biological models for studying iron chelating drugs |
Q47886701 | Bleomycin-detectable iron in plasma from Plasmodium vinckei vinckei-infected mice |
Q67540643 | Bleomycin-reactive iron in patients with acute non-lymphocytic leukemia |
Q35172888 | Calcium channels and iron uptake into the heart |
Q42821105 | Cleavage of folates during ethanol metabolism. Role of acetaldehyde/xanthine oxidase-generated superoxide |
Q41198667 | Clonal analysis of the effect of iron on human cytotoxic and proliferating T lymphocytes |
Q43609929 | Daily supplementation with iron increases lipid peroxidation in young women with low iron stores. |
Q73876492 | Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method |
Q28235657 | Dietary iron overload in the African and hepatocellular carcinoma. |
Q51208510 | Disordered vascular compliance in haemochromatosis. |
Q36711411 | Drug antioxidant effects. A basis for drug selection? |
Q44576221 | Effect of free radical scavengers and metal ion chelators on hydrogen peroxide and phenylhydrazine induced red blood cell lipid peroxidation |
Q46083931 | Effect of iron supplementation during lactation on maternal iron status and oxidative stress: A randomized controlled trial |
Q77328999 | Effect of transfusion on lipid peroxidation products in the plasma of thalassemic patients |
Q40626129 | Etiologies, consequences, and treatment of iron overload |
Q35685838 | Evaluation of iron overload |
Q43839985 | Ferroxidases and xanthine oxidase in plasma of healthy newborn infants |
Q41988056 | Formation of hydroxyl radicals in the presence of ferritin and haemosiderin. Is haemosiderin formation a biological protective mechanism? |
Q28645793 | Free radicals and hearing. Cause, consequence, and criteria |
Q40781838 | Free radicals in disease processes: a compilation of cause and consequence |
Q33867130 | Genetic and physiologic characterization of ferric/cupric reductase constitutive mutants of Cryptococcus neoformans |
Q70804097 | Growth of human tumor cell lines in transferrin-free, low-iron medium |
Q44443247 | HFE Mutation and Dietary Iron Content Interact to Increase Ischemia/Reperfusion Injury of the Heart in Mice |
Q47739258 | Haemochromatosis: an inherited metal and toxicity syndrome |
Q74516788 | Hemochromatosis at the intersection of classical medicine and molecular biology |
Q68802545 | Hepatic ferritin uptake and hepatic iron |
Q34408927 | Hepatocellular carcinoma and African iron overload |
Q37654789 | Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice |
Q38613963 | Immune cell functions in iron overload. |
Q37207161 | In vitro antioxidative activity of yellow tea and its in vivo preventive effect on gastric injury |
Q54171299 | Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis. |
Q40090410 | Intracellular iron overload leading to DNA damage of lymphocytes and immune dysfunction in thalassemia major patients. |
Q39180946 | Involvement of polyamines in iron(III) transport in human intestinal Caco-2 cell lines |
Q70383726 | Iron and infection |
Q54756580 | Iron enhancement of ascorbate toxicity. |
Q37087636 | Iron homeostasis and erythropoiesis |
Q34974326 | Iron metabolism in hemodialyzed patients - a story half told? |
Q37738515 | Iron overload in patients with myelodysplastic syndromes |
Q47237018 | Iron supplementation of iron-replete Indonesian infants is associated with reduced weight-for-age |
Q38648352 | Iron toxicity and oxygen radicals |
Q39650138 | Iron, iron-binding proteins and immune system cells |
Q50725581 | Iron-chelating and free-radical scavenging activities of microwave-processed green tea in iron overload. |
Q39581560 | Iron-chelating therapy |
Q41828536 | Iron-induced ascorbate oxidation in plasma as monitored by ascorbate free radical formation. No spin-trapping evidence for the hydroxyl radical in iron-overloaded plasma |
Q46445227 | Iron-induced myocardial and hepatic lysosomal abnormalities in the guinea pig. |
Q44770811 | Lack of hepatic transferrin receptor expression in hemochromatosis |
Q50524779 | Lack of non-transferrin-bound iron in heart transplant recipients. |
Q45780994 | Lipid peroxidation of human granulocytes (PMN) and monocytes by iron complexes |
Q90652303 | Low-molecular-mass iron complexes in blood plasma of iron-deficient pigs do not originate directly from nutrient iron |
Q88888632 | Low-molecular-mass iron in healthy blood plasma is not predominately ferric citrate |
Q71630063 | Measurement of iron and copper in biological systems: bleomycin and copper-phenanthroline assays |
Q40990292 | Monocyte-macrophage ferric reductase activity is inhibited by iron and stimulated by cellular differentiation |
Q40655666 | Multidentate pyridinones inhibit the metabolism of nontransferrin‐bound iron by hepatocytes and hepatoma cells |
Q46973687 | Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera |
Q34557036 | Nature of nontransferrin-bound iron |
Q46288212 | Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload |
Q73212248 | Nontransferrin-bound iron in serum of patients receiving bone marrow transplants |
Q64212180 | Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats |
Q34418689 | Oral iron chelation with deferiprone |
Q40607123 | Oral iron-chelating therapy: the L1 experience |
Q46492087 | Osteoporosis in African hemosiderosis: role of alcohol and iron |
Q41260212 | Oxidative damage and fibrogenesis |
Q43910637 | Oxidative status and malondialdehyde in beta-thalassaemia patients |
Q34232983 | Oxidative stress and labile plasmatic iron in anemic patients following blood therapy |
Q28082925 | Oxidative stress and the homeodynamics of iron metabolism |
Q36978230 | Oxygen Free Radicals and Human Diseases |
Q40458496 | Oxygen radicals, nitric oxide and human inflammatory joint disease |
Q40831402 | Pathogenesis of genetic haemochromatosis. |
Q47824609 | Pathophysiology of iron overload. |
Q33953623 | Pathophysiology of thalassaemia |
Q68308581 | Polynuclear iron complexes impair the function of polymorphonuclear granulocytes |
Q37633508 | Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II. |
Q46712890 | Quantitative evaluation of oxidative stress status on peripheral blood in beta-thalassaemic patients by means of electron paramagnetic resonance spectroscopy. |
Q36444526 | Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy |
Q37224329 | Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation |
Q35852267 | Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress |
Q32139753 | Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry |
Q44771263 | Serum markers of stored body iron are not appropriate markers of health effects of iron: a focus on serum ferritin |
Q44116574 | Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1. |
Q42767831 | Short-lasting accumulation in osteoid bone seams of radioactive iron injected as citrate into mice |
Q70381887 | Sicca syndrome with iron deposition in the salivary glands |
Q35818492 | Stainable bone iron in undecalcified, plastic-embedded sections. Occurrence in man related to the presence of "free" iron? |
Q38648357 | The development of iron chelating drugs |
Q70037720 | The effect of experimental iron-overload on splenic T cell function: analysis using cloning techniques |
Q52136810 | The effect of iron (Fe3+) on the cloning efficiency of human memory T4+ lymphocytes. |
Q44803416 | The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys |
Q41608115 | The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells |
Q67487116 | The role of iron in an acute model of skin inflammation induced by reactive oxygen species (ROS) |
Q36571701 | Transient iron overload with bleomycin detectable iron in the plasma of patients with adult respiratory distress syndrome |
Q73703028 | Unexpected effects of albumin on apoptosis induction by deferoxamine in vitro |
Q34750572 | VDAC2 and aldolase A identified as membrane proteins of K562 cells with increased expression under iron deprivation. |
Search more.